Pharmacoeconomics: NICE's approach to decision-making.

@article{Rawlins2010PharmacoeconomicsNA,
  title={Pharmacoeconomics: NICE's approach to decision-making.},
  author={Michael D Rawlins and David Barnett and Andrew Stevens},
  journal={British journal of clinical pharmacology},
  year={2010},
  volume={70 3},
  pages={346-9}
}
The National Institute for Health and Clinical Excellence (NICE) is a decision-maker. Where NICE reaches a positive conclusion about the use of a particular health technology (such as a pharmaceutical product) in the National Health Service (NHS), there is a legal requirement for the service to make it available if a patient’s physician considers it clinically appropriate [1]. Although this legal obligation does not apply to technologies recommended in NICE’s clinical guidelines, there is still… CONTINUE READING